Insider filing · MDGL
Carole Huntsman
Chief Commercial Officer
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
Carole Huntsman sold $449K of Madrigal Pharmaceuticals (MDGL)
Executed Jan 26, disclosed Jan 26, the same day.
Value, as filed
$449K
910 sh across 2 lots
Executed
Jan 26
the trade date, as filed
Disclosed
Jan 26
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CHCarole Huntsman (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $715K of MDGL (1,294 sh across 3 lots, as filed), executed Nov 21 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Carole Huntsman in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$181K419 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $715K
1,294 sh across 3 lots
Exec Nov 21 2025
Filed Nov 21 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $189K
563 sh × $335.00
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $116K
347 sh × $335.24
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $218K
688 sh × $316.92
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET